Bill Details
HR.2404 - 119th Congress
Status
Latest action
2025-03-27 - Referred to the House Committee on Energy and Commerce.
Introduced Date
2025-03-27
Policy Area
Health
Committees
View committees (1)
Sponsors
Cosponsors
View cosponsors (1)
8
0
0
AI Summary This summary was generated by AI from the bill text. AI can get information wrong.
This bill would require the Comptroller General of the United States to study how remote monitoring affects people who are prescribed opioid pain medicines. Within 18 months of becoming law, the Comptroller General would have to send Congress a report looking at whether remote monitoring helps patients, what it costs, how widely it is being used, and whether it should be expanded. The study would also suggest ways to improve access and coverage for this kind of monitoring, including possible changes to federal health care programs.
- Review the scientific evidence on whether remote monitoring helps people taking opioids, including health results and possible cost savings.
- Measure how common remote monitoring is now for opioid patients, including how it is used in other countries.
- Recommend ways to make remote monitoring more available and easier to get covered by health plans and federal programs.
- If helpful, identify which groups of patients might benefit the most from remote monitoring while using opioids.
Official Summaries
No summaries available
Current Full Text
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2404 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 2404
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 27, 2025
Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To provide for a study on the effects of remote monitoring on
individuals who are prescribed opioids.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Remote Opioid Monitoring Act of
2025''.
SEC. 2. PROVIDING FOR A STUDY ON THE EFFECTS OF REMOTE MONITORING ON
INDIVIDUALS WHO ARE PRESCRIBED OPIOIDS.
(a) In General.--Not later than 18 months after the date of
enactment of this Act, the Comptroller General of the United States
shall conduct a study and submit to the Committee on Energy and
Commerce of the House of Representatives and the Committee on Health,
Education, Labor, and Pensions and the Committee on Finance of the
Senate a report on the use of remote monitoring with respect to
individuals who are prescribed opioids.
(b) Report.--The report described in subsection (a) shall include--
(1) an assessment of scientific evidence related to the
efficacy, individual outcomes, and potential cost savings
associated with remote monitoring for individuals who are
prescribed opioids compared to such individuals who are not so
monitored;
(2) an assessment of the current prevalence of remote
monitoring for individuals who are prescribed opioids,
including the use of such monitoring for such individuals in
other countries; and
(3) recommendations to improve availability, access, and
coverage for remote monitoring for individuals who are
prescribed opioids, including through changes to Federal health
care programs (as defined in section 1128B of the Social
Security Act (42 U.S.C. 1320a-7b)) and, if determined
appropriate by the Comptroller General, an identification of
cohorts of individuals who stand to benefit the most from
remote monitoring when prescribed opioids.
<all>